RxDoctor Payments DataLook up a doctor →

Ashok Jacob

Rheumatology · Annapolis, MDNPI 1467676759

Payments from drug & device makers

$31,576in general payments, 2019–2025

Across 874 payments — averaging $36.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$10K
  • AbbVie$7K
  • Novartis$2K
  • UCB, Inc.$2K
  • Lilly USA, LLC$1K
  • Johnson & Johnson$1K
  • plus $8K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)120$10,390
AbbVie134$7,411
Novartis69$1,583
UCB, Inc.90$1,577
Lilly USA, LLC59$1,457
Johnson & Johnson(2 entities)65$1,373
AstraZeneca(2 entities)45$1,159
Pfizer59$1,105
Aurinia Pharma U.S., Inc.28$741
E.r. Squibb & Sons, L.L.C.36$699
GSK15$353
Sobi, Inc10$318
Fresenius Kabi USA, LLC11$312
Genentech USA, Inc.15$283
Organon19$271
Radius Health, Inc.10$269
Mallinckrodt Enterprises LLC10$262
ANI Pharmaceuticals, Inc.12$234
Mallinckrodt Hospital Products Inc.7$177
US Oncology Corporate, Inc.3$154
Boehringer Ingelheim6$149
Sanofi5$140
Sandoz6$137
Regeneron Healthcare Solutions, Inc.5$115
Bristol Myers Squibb7$113
Tersera Therapeutics LLC4$105
Cardinal Health 110 LLC1$100
Invivyd Inc4$99
Janssen Scientific Affairs, LLC1$89
Kyowa Kirin, Inc.3$54
Mylan Institutional Inc.2$48
Pacira Therapeutics, Inc.2$45
Bioventus LLC1$42
Hikma Pharmaceuticals USA2$40
Cumberland Pharmaceuticals, Inc.1$35
Almatica Pharma LLC1$32
Fidia Pharma USA Inc.1$28
Tonix Medicines, Inc.1$18
Medtronic1$17
Bio Products Laboratory USA, Inc.1$16
Medexus Pharma, Inc.1$13
Octapharma USA, Inc.1$12

How this compares

$31,576 in reported general payments places this provider in the 75th percentile of 173 rheumatology providers in Maryland.

See all rheumatology providers in Maryland →

Medicare billing

Part B allowed, 2024
$4,266,006
Medicare patients
373
Services billed
195,820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Annapolis

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →